foxo4 dri senolytic 2023 foxo4-dri peptide mouse study 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI FOXO4-DRI 10MG | Alpha Omega
FOXO4 DRI 10MG Alpha Omega Peptide Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29



